NovaMedica’s goal is not only to become a market leader in its key therapeutic areas but mostly to provide patients and doctors with the access to the most advanced and effective products and technologies. Our portfolio includes pharmaceutical and other medical products, diagnostic equipment, medical devices and technologies designed to provide a comprehensive solution for the whole range of interrelated problems and to bring a real value to the Russian patients.
Key development areas of NovaMedica’s product portfolio are:
Russia has eliminated the shortage of therapies for epilepsy and thyroid diseases
23 May 2022
FDA Publishes Draft Guidance on Quality Assessments
23 May 2022
New polymer coating for improved cancer targeting of nanomedicine
20 May 2022
Preparation is key: the role of scientific due diligence in successful partnerships
20 May 2022